According to data from Benzinga Pro, during Q4, Apyx Medical's (NASDAQ:APYX) reported sales totaled $16.82 million. Despite a 52.53% increase in earnings, the company posted a loss of $2.01 million.
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 50 percent decrease over losses of $(0.04) per share from the
Apyx Medical (NASDAQ:APYX) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement.
Analysts estimate that Apyx Medical will report an earnings per share (EPS) of $-0.11.